UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 WASHINGTON, D.C. 20549

FORM 10-QSB

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2007

OR

[ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE

EXCHANGE ACT OF 1934

From the transition period from __________ to ___________

Commission file number 000-30074

PAIVIS, CORP.

(Exact name of registrant as specified in its charter)

Nevada	00030074	86-0871787
(State or other Jurisdiction	(Commission File	(IRS Employer
of Incorporation)	Number)	Identification No.)

#400-3475 Lenox Road, Atlanta Georgia 30326

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (404) 601-2885

Indicate by check mark whether the registrant (1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period of time that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, or an accelerated filer. See definition of "accelerated filer and large accelerated filer" in Rule 12b-2 of the Exchange Act. (Check one): Large accelerated filer [ ] Accelerated filer [ ] Non-accelerated filer [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act. Yes [ ] No [X]

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date. As of August 10, 2007,  42,385,068shares of Common Stock of the issuer were issued and outstanding.

-1-

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS.

PAIVIS, CORP.

(Formerly APO Health, Inc.)

INTERIM CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2007

(Unaudited)

(Stated in U.S. Dollars)

F-1

PAIVIS, CORP.

(Formerly APO Health, Inc.)

INTERIM CONSOLIDATED BALANCE SHEETS

(Stated in U.S. Dollars)

	June 30 2007 (unaudited)			September 30 2006
ASSETS
Current
Cash	$	4,469		$	88,678
Goods and Services Tax recoverable		7,476			7,453
Accounts Receivable		534,921			407,034
Prepaid expense, advances and other		15,777			28,009
		562,643			531,174
Capital Assets		47,620			100,961
Goodwill		6,249,955			6,249,955
Minority Interest in Subsidiaries		(7,147	)		(7,147	)
	$	6,853,071		$	6,874,943
LIABILITIES
Current
Accounts payable and accrued liabilities	$	6,050,880		$	4,960,011
Loans and advances payable		2,860,112			2,655,121
		8,910,992			7,615,132
STOCKHOLDERS’ DEFICIENCY
Capital Stock
Authorized:
125,000,000 common shares par value $0.0002 per share
15,000,000 preferred shares, par value $0.0001 per share
Issued and outstanding:
41,514,739 common shares at June 30, 2007     and 30,558,352 at September 30, 2006		8,302			6,111
No Series A preferred shares at June 30, 2007,     and 792,592 at September 30, 2006		-			79
3,000,750 Series B preferred shares at June 30, 2007,     and at September 30, 2006		300			300
Additional paid-in capital		16,687,832			16,448,833
Accumulated Deficit		(18,754,355	)		(17,195,512	)
		(2,057,921	)		(740,190	)
	$	6,853,071		$	6,874,943

The accompanying notes are an integral part of these consolidated financial statements.

F-2

 PAIVIS, CORP.

(Formerly APO Health, Inc.)

INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 (Stated in U.S. Dollars)

	THREE MONTHS ENDED June 30						NINE MONTHS ENDED June 30
	2007			2006			2007			2006
Revenue
Telecom	$	1,322,439		$	1,417,623		$	4,559,351		$	4,557,193
Cost of Sales		1,139,682			1,427,034			3,652,754			4,182,713
		182,757			(9,411	)		906,597			374,480
Expenses
Consulting		95,171			103,000			353,058			503,903
Debt retirement expense		-			23,624			24,111			1,033,603
Interest Expense		22,455			-			165,855			-
Marketing		3,502			-			22,301			8,186
Office, administration and sundry		408,230			621,370			854,240			902,619
Professional fees		212,561			118,834			488,103			274,923
Wages and benefits		171,246			178,495			557,774			595,197
		616,255			1,045,323			2,168,532			3,318,431
Loss Before The Following		(730,408	)		(1,054,734	)		(1,558,845	)		(2,943,951	)
Forgiveness of Debt		-			-			-			(1,015	)
Net Loss For The Period	$	(730,408	)	$	(1,054,734	)	$	(1,558,845	)	$	(2,942,936	)
Net Loss Per Share,     Basic and diluted	$	(0.02	)	$	(0.08	)	$	(0.05	)	$	(0.60	)
Weighted Average Number Of Common Shares Outstanding		32,464,268			13,988,049			30,691,563			4,868,063

The accompanying notes are an integral part of these consolidated financial statements.

F-3

 PAIVIS, CORP.

(Formerly APO Health, Inc.)

INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(Stated in U.S. Dollars)

	NINE MONTHS ENDED JUNE 30
	2007			2006
Cash Flows From Operating Activities
Loss for the period from continuing operations	$	(1,558,845	)	$	(2,942,936	)
Adjustments To Reconcile Net Loss To Net Cash Used By Operating Activities
Amortization & Depreciation		53,343			153,097
Stock based compensation		-			1,009,580
Issue of common stock for expenses		217,000			229,180
Issue of common stock for debt		-			993,624
Debt Retirement Inducement Expense		24,111			-
Change in working capital items:
Goods and Services Tax recoverable		(24	)		(5,581	)
Accounts receivable		(127,887	)		(34,583	)
Prepaid expense		12,232			(38,055	)
Accounts payable and accrued liabilities		1,090,869			(95,359	)
Other Adjustments, net		-			253,227
		(289,200	)		(477,806	)
Cash Flows From Financing Activities
Shares issued for cash		-			464,032
Loans and advances payable		204,991			92,706
		204,991			556,738
(Decrease) Increase In Cash		(84,209	)		78,932
Cash, Beginning Of Period		88,678			5,660
Cash, (Bank Indebtedness) End Of Period	$	4,469		$	84,592
Supplemental Disclosure of Non Cash Financing and Investing Activities
Shares issued for debt		241,111			993,624
Supplemental Disclosure Of Cash Flow Financing and Investing Activities
Interest paid	$	231		$	11,281
Income taxes paid		-			-

The accompanying notes are an integral part of these consolidated financial statements.

F-4

PAIVIS, CORP.

(Formerly APO Health, Inc.)

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2007

(Unaudited)

(Stated in U.S. Dollars)

1.           NATURE OF OPERATIONS

Organization

The Company was incorporated in the State of Nevada, U.S.A., on April 28, 1997.

On April 21, 2006, PAIVIS, Corp. (f/k/a APO Health, Inc)., a Nevada corporation (“APO”), entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) with APO Health Acquisition Corp, Inc., a Nevada corporation and wholly-owned subsidiary of APO (“APO Acquisition”), and Jupiter Global Holdings, Corp., a Nevada corporation (“Jupiter”). As per the Merger Agreement provided that upon the terms and subject to the conditions set forth in the Merger Agreement, APO Acquisition merged with and into Jupiter, with Jupiter being the surviving corporation and a wholly-owned subsidiary of APO.   Historical Financial Statements presented are those of Jupiter Global Holdings Corp.

Business Activities

The Company’s business operations consist of telecommunications switching services. The Company is a facility-based wholesale telecommunications carrier that delivers many application/value-added services within the prepaid services space. The Company operates and maintains a robust switching facility, offering over 16,000 ports with connectivity to most of the tier 1 carriers in the US and manages an extensive international (A-Z) network.  In addition to the wholesale business, The Company maintains a large retail distribution network for direct to consumer services. The Company’s products are sold through approximately 3,000 retail outlets in the United States and our distribution is rapidly expanding.

Going Concern

Since inception, the Company has suffered recurring losses, net cash outflows from operations and, at June 30, 2007, has accumulated a deficit of $18,754,355 and a working capital deficiency of $8,348,349.  The Company expects to continue to incur substantial losses to continue the growth of its business.  Since its inception, the Company has funded operations through common stock issuances and related party loans in order to meet its strategic objectives.  Management believes that sufficient funding will be available to meet its business objectives, including anticipated cash needs for working capital, and is currently evaluating several financing options.  However, there can be no assurance that the Company will be able to obtain sufficient funds to continue the business growth of and, if successful, to grow the sale of its products and services under development.  As a result of the foregoing, there exists substantial doubt about the Company’s ability to continue as a going concern.  These consolidated financial statements do not include any adjustments that might result if the Company is unable to realize its assets and settle its obligations in the normal course of business.

F-5

PAIVIS, CORP.

(Formerly APO Health, Inc.)

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2007

(Unaudited)

(Stated in U.S. Dollars)

1.           NATURE OF OPERATIONS (cont)

The accompanying unaudited interim consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America.  Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of consolidated financial statements for a period necessarily involves the use of estimates which have been made using careful judgment.  These unaudited interim consolidated financial statements should be read in conjunction with the financial statements for the 12 months ending September 30, 2006 in the Form 10-KSB as filed with the Securities and Exchange Commission.

The consolidated financial statements have, in management’s opinion, been properly prepared within reasonable limits of materiality and within the framework of the significant accounting policies summarized below:

Consolidation

These consolidated financial statements include the accounts of the Company, its 100% owned subsidiaries, Jupiter Global Holdings, Corp., MACRO Communications, Inc., Trucall Solutions Inc., RRUN Labs Incorporated, LIVESTAR Entertainment Canada Inc., 1615496 Ontario Ltd., 1614718 Ontario Inc., LIVESTAR Entertainment Establishment Ltd., LIVESTAR Entertainment Events International Inc., its 67% owned subsidiary, RAHX, Inc., and its 51% owned subsidiary LIVE & Cool One, Inc..

2.            SIGNIFICANT ACCOUNTING POLICIES

a)   Income Taxes

The Company has adopted Statement of Financial Accounting Standards No. 109 – “Accounting for Income Taxes” (SFAS 109). This standard requires the use of an asset and liability approach for financial accounting and reporting on income taxes. If it is more likely than not that some portion or all of a deferred tax asset will not be realized, a valuation allowance is recognized.

b)   Amortization and Depreciation

Capital assets are being amortized over their estimated useful lives on the straight-line basis at the following rates:

Computer equipment	3 years
Telecom Equipment	5 years

F-6

PAIVIS, CORP.

(Formerly APO Health, Inc.)

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2007

(Unaudited)

(Stated in U.S. Dollars)

2.            SIGNIFICANT ACCOUNTING POLICIES (cont)

c)    Stock Based Compensation

The Company has adopted the use of Statement of Financial Accounting Standards No. 123R , “Share-Based Payment”, (SFAS No. 123R)   This Statement requires an entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). That cost is recognized over the period during which an employee is required to provide service in exchange for the award—the requisite service period (usually the vesting period). No compensation cost is recognized for equity instruments for which employees do not render the requisite service.   This Statement supersedes APB Opinion No. 25, “Accounting for Stock Issued to Employees”, and its related implementation guidance and eliminates the alternative to use Opinion 25’s intrinsic value method of accounting that was provided in Statement 123 as originally issued.

d)   Financial Instruments

The Company’s financial instruments consist of cash, accounts receivable, Goods and Services Tax recoverable, accounts payable and accrued liabilities, and loans and advances payable.

Unless otherwise noted, it is management’s opinion that this Company is not exposed to significant interest or credit risks arising from these financial instruments.  The fair value of these financial instruments approximates their carrying values, unless otherwise noted.

e)   Net Loss Per Share

Basic earnings per share is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding in the period.  Diluted earnings per share takes into consideration common shares outstanding (computed under basic earnings per share) and potentially dilutive common stock equivalents including warrants, options and convertible instruments.  Diluted loss per share equals loss per share as the exercise of any common stock equivalents would be anti-dilutive in periods with losses.

F-7

PAIVIS, CORP.

(Formerly APO Health, Inc.)

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2007

(Unaudited)

(Stated in U.S. Dollars)

2.            SIGNIFICANT ACCOUNTING POLICIES (cont)

f)   Foreign Currency Translation

Transaction amounts denominated in foreign currencies are translated at exchange rates prevailing at transaction dates.  Carrying values of monetary assets and liabilities are adjusted at each balance sheet date to reflect the exchange rate at that date.  Non-monetary assets and liabilities are translated at the exchange rate on the original transaction date.  Gains and losses from restatement of foreign currency monetary and non-monetary assets and liabilities are included in the statements of operations.  Revenues and expenses are translated at the rates of exchange prevailing on the dates such items are recognized in the statements of operations.

g)   Revenue Recognition

The Company recognizes revenue upon the sale and activation of a telephone calling card.

3. CAPITAL ASSETS

	June 30, 2007
				ACCUMULATED
	COST			AMORTIZATION AND DEPRECIATION			NET BOOK VALUE
Computer equipment		$	18,016		$	18,016		$	-
Telecom equipment			1,063,065			1,015,445			47,620
		$	1,081,081			1,033,461			47,620
	June 30, 2006
				ACCUMULATED
	COST			AMORTIZATION AND DEPRECIATION			NET BOOK VALUE
Computer equipment		$	18,016		$	16,160		$	1,856
Telecom equipment			1,063,065			914,799			148,266
		$	1,081,081			930,959			150,122

At June 30, 2007 (June 30, 2006) the net book value of equipment serving as collateral for equipment and bank borrowings is $47,620 ($148,266).

F-8

PAIVIS, CORP.

(Formerly APO Health, Inc.)

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2007

(Unaudited)

(Stated in U.S. Dollars)

4.           OBLIGATIONS UNDER CAPITAL LEASES

Included within Loans & Advances Payables is equipment under capital leases at June 30, 2007 and 2006 as follows:

	June 30 2007		June 30 2006
Cost	$	-	$	923,572
Less Accumulated Depreciation		-		806,193
Net Book Value		-		117,379

As at June 30, 2007, there are no more capital leases outstanding with the Company.

5.            CONTINGENCIES

Litigation

The Company is in settlement negotiations with a telecom carrier who has filed proceedings for delinquent payments.  Amounts payable to this vendor have been recorded in accounts payable as at June 30, 2007.  Management believes the ultimate disposition of these matters will not have a material adverse impact on the operations or financial condition of the Company.

The Company is a defendant in a lawsuit filed by a former service provider.  Management believes the claim is without merit and that any potential judgement against the Company would not have a material adverse impact on the operations or financial condition of the Company.  Accordingly no contingent liability has been accrued.

F-9

PAIVIS, CORP.

(Formerly APO Health, Inc.)

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2007

(Unaudited)

(Stated in U.S. Dollars)

6. LOANS AND ADVANCES

All loans and advances payable are past due or are repayable within one year, unsecured, not convertible into the Company stock.  At the period ending June 30, 2007, loans and advances consisted of:

	June 30 2007		June 30 2006
Loans & Advances
- past due	$	1,208,192	$	1,208,192
- due within one year		1,651,920		647,745
Total Loans & Advances Payable	$	2,860,112	$	1,855,937

The past due loans and advances were issued in the period ended June 30, 2007, and the holders have not demanded payment.

Of the Loans and Advances, additional details have been listed below:

	June 30 2007		June 30 2006
Bears no interest	$	418,565	$	418,565
Bears no interest, paid Loan fee of  $176,957and $ 165,958		1,732,504		802,696
Bears an interest rate of 8 %		126,031		51,664
Bears an interest rate of 5%		116,320		116,320
Bears an interest rate 8.8%		466,692		466,692
Total Loan & Advances Payable	$	2,860,112	$	1,855,937

F-10

PAIVIS, CORP.

(Formerly APO Health, Inc.)

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2007

(Unaudited)

(Stated in U.S. Dollars)

7.           WARRANTS OUTSTANDING

As at June 30, 2007, share purchase warrants were outstanding for the purchase of common shares as follows:

NUMBER OF SHARES		PRICE PER SHARE		EXPIRY DATE
	2,250,000	$	1.50	June 1, 2009
	200,000	$	1.50	June 1, 2009
	2,450,000

A summary of the changes in shares which may be purchased on exercise of warrants for the year ended June 30, 2007is presented below:

	NUMBER OF SHARES		WEIGHTED AVERAGE EXERCISE PRICE
Balance, September 30, 2005		0
Granted		2,450,000		1.50
Balance, September 30, 2006		2,450,000	$	1.50
No Warrant Activity		0
Balance, June 30, 2007		2,450,000	$	1.50

At June 30, 2007, a total of 2 warrants remain issued and outstanding, and underlie the shares listed in the table above.

F-11

PAIVIS, CORP.

(Formerly APO Health, Inc.)

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2007

(Unaudited)

(Stated in U.S. Dollars)

8.           BUSINESS SEGMENTS

The Company currently operates in a single business segment, “Telephone Communications”, in a single geographic area, North America.

9.           RELATED PARTY TRANSACTIONS

a)   Included in accounts payable at June 30, 2007 is $718,658 (2006 - $502,852) owing to directors or companies controlled by directors.

b)   Included in loans and advances payable at June 30, 2007 is $120,938 (2006 - $23,671) owing to directors or a companies controlled by directors.

c)   During the period ended June 30, 2007, the Company incurred $270,000 (2006- $270,000) in consulting expense to companies controlled by directors.

d)   During the period ended June 30, 2007, the Company incurred no expenses (2006 - $28,490) in administration, office, and equipment rental expenses with companies controlled by directors.

F-12

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

FORWARD-LOOKING STATEMENTS

Except for the historical information and discussions contained herein, statements contained in this Form 10-QSB may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially, including any projections of earnings, revenues, or other financial items; any statements of the plans, strategies, and objectives of management for future operation; any statements concerning proposed new products, services, or developments, any statements regarding future economic conditions or performance, statements of belief, statements of assumptions underlying any of the foregoing and other risks, uncertainties and factors discussed elsewhere in this Form 10-QSB or in the Company’s other filings with the Securities and Exchange Commission

OVERVIEW

Paivis Corp.’s (“Paivis”, the “Company” or the “Registrant”) business operations commenced June 2000 and consist of telecommunications switching services. Paivis is facility-based wholesale telecommunications carrier that delivers many application/value-added services within the prepaid services space. The Company operates and maintains a robust switching facility, offering over 16,000 ports with connectivity to most of the tier 1 carriers in the US and manages an extensive international (A-Z) network.  In addition to the wholesale business, Paivis maintains a large retail distribution network for direct to consumer services. Our products are sold through approximately 5,000 retail outlets in the United States and our distribution is rapidly expanding.

The future growth of the Company is focused on implementing a plan of growth of our current business operations, and also growth through acquisitions. The Company is currently in discussions with several acquisition candidates.

The following analysis discusses changes in the financial condition and results of operations at and for the three months periods ended on June 30, 2007 and June 30, 2006 and should be read in conjunction with our unaudited consolidated financial statements and the notes thereto. This subsection of MD&A is an overview of the important factors that management focuses on in evaluating our businesses, financial condition and operating performance, our overall business strategy and our earnings, if any, for the periods covered.

OUR COMPANY HISTORY

Paivis,Corp, (formerly known as APO Health, Inc., Internetfinancialcorp.com, Caribbean Ventures Inc., and Dom Caribe Ltd.)  was originally incorporated in the State of Nevada in April 1997. From mid 2001 until mid 2006, our predecessor, APO Health, Inc. was primarily engaged in the business of wholesale medical products. In May of 2006 the Registrant completed a Merger transaction (details below) where effectively Jupiter Global Holdings, Corp. became a wholly owned subsidiary of the Registrant. With completion of the Merger transaction the Registrant effected a sale of the APO Health subsidiary (“APO Health NY”) responsible for the business of wholesale medical products (details below). Furthermore, due to the Merger transaction and subsequent sale of APO Health NY the Registrants business will be primarily engaged in the core operating business of Jupiter, prepaid technologies and telecom-based services. 

Headquartered in Atlanta, Georgia, the Company is publicly traded and Paivis, Corp. presently conducts its business operations through its operating subsidiaries located in the United States.

OUR BUSINESS OPERATIONS

Paivis’ present business operations commenced June 2000 and involve providing prepaid long distance services. We generate revenues through the domestic and foreign sale of a variety of telecommunications products and services, such as prepaid calling cards, prepaid wireless service and international wholesale termination. Our products are sold through approximately 5,000 retail outlets in the United States and our distribution is rapidly expanding.

The discussion below of our performance is based upon our consolidated financial statem ents as of and for the three months periods ended June 30, 2007 and June 30, 2006.

-2-

RESULTS OF OPERATIONS

FOR THE THREE MONTH PERIOD ENDED JUNE 30, 2007

For the three month period ended June 30, 2007, the Company earned revenues of $1,322,439. The revenues were from sales of airtime related to telephone calling cards.

During the three month period ended June 30, 2007, the Company incurred operational expenses of $616,255. These operating expenses included: consulting fees of $95,171, wages and benefits of $171,246, and professional fees of $212,561 for the three month period ending June 30, 2007.

During the three month period ended June 30, 2007, the Company incurred a net loss from operations of $730,408.

FOR THE THREE MONTH PERIOD ENDED JUNE 30, 2007, COMPARED TO THE THREE MONTH PERIOD ENDED JUNE 30, 2006.

For the three month period ended June 30, 2007, the Company earned revenues of $1,322,439 as compared to revenues of $1,417,623 for the same period ended June 30, 2006.  The changes in revenues in 2007 are a result of the Company’s continued efforts to restructure its business and product offerings, and its efforts to minimize the sale of products with lower margins.

For the three month period ended June 30, 2007, the Company incurred operational expenses of $616,255 as compared to $1,045,323 during the same period in the previous year. These operating expenses included: consulting fees of $95,171 and $103,000, wages & benefits of $171,246 and $178,495, and professional fees of $212,561 and $118,834 for the three month period ended June 30, 2007 and 2006, respectively. The variation in expenses from June 30, 2007 as compared to the same period in the previous year is due to the continued efforts to restructure its business operations and reduction of debt.

The Company incurred a net loss from operations of $730,408 for the fiscal quarter ended June 30, 2007, as compared to $1,054,734 for the same period in the previous year.

SIGNIFICANT ACCOUNTING POLICIES

Our significant accounting policies have been outlined in our 10KSB filing for the year ending September 30, 2006, and are thus incorporated by reference. We have had no significant changes to our accounting policies or assumptions in the three month period ending June 30, 2007.

Liquidity and Financial Condition As Of June 30, 2007

We had cash-on hand totaling $ 4,469 as of June 30, 2007.

We believe that our currently available working capital provided by operating activities may be insufficient to meet our operations at our current level and working capital and capital expenditure needs over the next 12 months. Our future capital requirements will depend on many factors, including our rate of revenue growth, the expansion of our marketing and sales activities, the timing and extent of spending to support product development efforts and expansion into new territories, the timing of introductions of new products or services, the timing of enhancements to existing products and services and the timing of capital expenditures. Also, we may make investments in, or acquisitions of, complementary businesses, services or technologies which could also require us to seek additional equity or debt financing. To the extent that available funds are insufficient to fund our future activities, we may need to raise additional funds through public or private equity or debt financing. Additional funds may not be available on terms favorable to us or at all.

-3-

Management plans on initiating a series of securities offerings to raise the investment capital needed to meet our acquisition and development plans. Paivis hopes to secure the financing to satisfy the capital needs through the execution of various funding methods, primarily financing through, private placement investments or debt financing. Paivis hopes to achieve this by securing relationships with accredited individual investors, investment bankers, venture capitalists, hedge funds and/or finance investment advisors that have the experience and relationships to aid Paivis with its capital raising efforts. The source of the capital may be comprised of a mix of principal shareholders, private investors and venture capital companies.

Management is in the process of developing and finalizing an extensive  debt restructuring and reduction plan. At present, management anticipates that the  plan may include negotiating with our creditors with a view towards converting some of our outstanding obligations  to equity on terms acceptable to our creditors, which may included both preferred and common stock and possibly the sale or discontinuation of business units or subsidiaries that may be dormant, non operational and debt heavy. Any stock conversions may be done at prices which are at a discount to the market price of the Company’s common stock, due to the depressed market for the Company’s securities and further due to the fact that conversion of any debt to equity would result in the issuance of restricted securities to such creditors. Accordingly, such conversion will  result in additional and possibly substantial dilution to existing shareholders. However, converting the Company’s debt obligations to equity removes liabilities from our balance sheet and ultimately management believes will improve shareholder value and the opportunity to raise additional capital for our growth and development.

If needed capital investment for our acquisitions or developments is not available, in whole or in part, we intend to delay the implementation plan regarding our acquisitions or development plans until sufficient investment capital becomes available. We cannot give any assurances that we will raise sufficient investment capital to meet the business plan. In addition to delays to the implementation plan regarding our acquisition or development plans due to insufficiency of investment capital, we may suffer other consequences, including but not limited to the following: We may have to significantly alter the scope of our business plan and subsequent capital requirements; We may have to suspend or discontinue operations of one or more of our business units or; we may have to suspend or discontinue operations of the Company if we become insolvent as a result.

Until planned acquisitions and operating activities begin to produce significant revenues and subsequent positive cash flow, we will be reliant on capital received from private placements, loans, and the exercise of options and warrants.

OFF-BALANCE SHEET ARRANGEMENTS

The Company does not have any off-balance sheet arrangements that are likely to have a current or future effect on the Company's financial condition, revenues or expenses, results of operations or capital resources.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

ITEM 4. CONTROLS AND PROCEDURES.

As of the end of the period covered by this report the Company conducted an evaluation, under the supervision and with the participation of its principal executive officer and principal financial officer, of the Company's disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act). Based upon this evaluation, the Company's principal executive officer and principal financial officer concluded that the Company's disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is: (1) accumulated and communicated to the Company's management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure; and (2) recorded, processed, summarized and reported, within the time periods specified in the Commission's rules and forms. There was no change in the Company's internal controls or in other factors that could affect these controls during the Company's last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company's s internal control over financial reporting.

-4-

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

From time to time, the Company is involved in litigation matters in the ordinary course of its telecommunications business. Management has sought to resolve any disputes with vendors, creditors and others that may have claims against the Company arising from the day-to-day operations of our business. During the period covered by this report, no such litigation or other disputes have arisen that were not previously disclosed by the Company in one or more prior reports.

The Company previously filed suit against its former stock transfer agent, Jack Donnelly and his wholly-owned company, Executive Registrar & Transfer, Inc. (“Executive Registrar”), in Arapahoe County District Court, Colorado , being Case No. 2007-CV-307. The Company initiated this lawsuit in order obtain a court order compelling Executive Registrar to turn over all of the Company’s stock transfer records to our new stock transfer agent, Corporate Stock Transfer, Inc. of Denver, Colorado. This lawsuit has been settled by the parties after Executive Registrar agreed to relinquish all of our corporate and stock transfer records. However, the dismissal of this lawsuit was without prejudice to the Company’s ability to refile a lawsuit against the same defendants in the same court for the purpose of recovering monetary losses sustained as a result of Executive Registrar’s refusal to abide by regulations promulgated by the Securities and Exchange Commission and in causing undue and serious delays in the issuance of our common stock to the former shareholders of Jupiter Global Holdings Corp. as required by our merger that was effective on May 18, 2006.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

In July 2007, the Board of Directors approved the issuance of 600,000 common shares for additional consideration to  a lender to provide  loans to the Company. The offer and sale of these shares  was exempt from registration requirements of § 5 of the Securities Act of 1933,  under § 4(2) of the Securities Act of 1933, as amended, as the issuance did not involve any public offering of the Company’s  securities.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

None.

ITEM 5. OTHER INFORMATION.

 Additional Information Regarding The Company change of Transfer Agents

On April 17, 2007, Corporate Stock Transfer, Inc.  notified us that it had taken possession of the necessary stock transfer records from Executive Transfer.

In May, 2007, Corporate Stock Transfer and the registrant were approved by the Depository Trust Company and Corporate Stock Transfer reported to us that it began to make significant headway in completing open deliveries of our common stock and the exchange of shares of our common stock for the outstanding shares of Jupiter Global Holding Corp. (“Jupiter”), as required in our merger with Jupiter.

As of the date of this report the Company, specifically Paivis management, asks for all new shareholders from Jupiter to notify their broker dealer to contact the new stock transfer agent to aid in the expediting of the delivery of their Paivis certificates. A number of broker dealers have not contacted the new transfer agent despite communication that has been made on behalf of the Company or have contacted the new transfer agent but have not submitted the list of beneficial holders. Any further delays in communication and cooperation from the broker-dealers representing Jupiter shareholders may result in additional setbacks in issuing replacement Paivis shares to the shareholders of those broker-dealers.

Any shares of our common stock issued and delivered after December 29, 2006 counter-signed by Executive Registrar are deemed to be unauthorized and will be canceled when presented to the new stock transfer agent, as that is the effective date of termination of Executive Registrar.

The Company is working closely with the new transfer agent to execute all open matters related to the issuance of certificates and expects to be complete in the upcoming weeks.

ITEM 6. EXHIBITS.

31.1 Certification by Gregory Bauer, Chief Executive Officer and Principal Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1 Certification by Gregory Bauer, Chief Executive Officer and Principal Financial Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

-5-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	PAIVIS, CORP.
Date: August 20, 2007	By:	/s/  Gregory Bauer
		Gregory Bauer, Chief Executive Officer, Acting Principal Accounting Officer

-6-